NCT02101853 2025-12-01Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting669 enrolled 14 charts
NCT01371981 2025-11-26Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting1,645 enrolled 32 charts